These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Drug dependence and withdrawal in chronic pain patients]. Wörz R Fortschr Med; 1994 Jun; 112(16):229-31. PubMed ID: 8070745 [TBL] [Abstract][Full Text] [Related]
3. [Response to treatment of chronic daily headache with analgesic abuse]. Iñiguez C; Larrodé P; Mauri JA; Morales F Neurologia; 1998 May; 13(5):214-7. PubMed ID: 9646627 [TBL] [Abstract][Full Text] [Related]
4. [Analgesic abuse and psychiatric comorbidity in headache patients]. Radat F; Irachabal S; Swendsen J; Henry P Encephale; 2002; 28(5 Pt 1):466-71. PubMed ID: 12386550 [TBL] [Abstract][Full Text] [Related]
5. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Fumal A; Laureys S; Di Clemente L; Boly M; Bohotin V; Vandenheede M; Coppola G; Salmon E; Kupers R; Schoenen J Brain; 2006 Feb; 129(Pt 2):543-50. PubMed ID: 16330505 [TBL] [Abstract][Full Text] [Related]
6. Effect of valproic acid on withdrawal therapy in patients with overuse of chronic daily headache medications. Coskun O; Ucler S; Cavdar L; Inan LE J Clin Neurosci; 2007 Apr; 14(4):334-9. PubMed ID: 16647854 [TBL] [Abstract][Full Text] [Related]
7. Opiate and opioid use in patients with refractory headache. Ziegler DK Cephalalgia; 1994 Feb; 14(1):5-10. PubMed ID: 8200026 [TBL] [Abstract][Full Text] [Related]
8. Drug treatment of migraine: Part I. Acute therapy and drug-rebound headache. Moore KL; Noble SL Am Fam Physician; 1997 Nov; 56(8):2039-48, 2051-4. PubMed ID: 9390098 [TBL] [Abstract][Full Text] [Related]
9. [Analgesic-induced chronic headache]. Le Jeunne C Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS50-3. PubMed ID: 11435995 [TBL] [Abstract][Full Text] [Related]
13. Medication overuse headache. Ward TN Prim Care; 2004 Jun; 31(2):369-80, vii. PubMed ID: 15172512 [TBL] [Abstract][Full Text] [Related]
14. Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria. Radat F; Creac'h C; Guegan-Massardier E; Mick G; Guy N; Fabre N; Giraud P; Nachit-Ouinekh F; Lantéri-Minet M Headache; 2008 Jul; 48(7):1026-36. PubMed ID: 18081820 [TBL] [Abstract][Full Text] [Related]
15. Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. Elander J; Lusher J; Bevan D; Telfer P; Burton B J Pain Symptom Manage; 2004 Feb; 27(2):156-69. PubMed ID: 15157040 [TBL] [Abstract][Full Text] [Related]
16. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study. Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816 [TBL] [Abstract][Full Text] [Related]